Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Menorrhagia × Medroxyprogesterone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Menorrhagia 1 Leiomyoma 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

asoprisnil 6 estradiol, norethindrone drug combination 5 elagolix 4 Estradiol 4 vilaprisan 3 relugolix 3 Norethindrone Acetate 3 linzagolix 2 Uterine Artery Embolization 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Hysterectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡